Skip to main content
. 2018 Dec;10(12):6624–6635. doi: 10.21037/jtd.2018.11.03

Table 4. The AUC of each model validated in different pathological stages. Because sample size (n=9) of stage II in validation set is too small to evaluate, we combine stage I and II for analysis.

Model AUC in stage I and II (n=63) AUC in stage III (n=76)      AUC in stage IV (n=61)
MClinical 0.630 0.800 0.617
MRadiomics 0.755 0.742 0.736
MRadiomics+Clinical 0.713 0.838 0.718
MMCNNs 0.767 0.815 0.848
MMCNNs+Clinical 0.800 0.860 0.847
MRadiomics+MCNNs 0.771 0.818 0.839
MRadiomics+MCNNs+Clinical 0.803 0.861 0.854

MCCNs, multi-level residual CNNs; CNN, convolutional neural network; AUC, area under the receiver operating characteristic curve.